Concerns are frequently raised in the pharmaceutical industry over the danger that when clinical trials are outsourced to contact research organisations (CROs), ethical protections might take a backseat to quicker and cheaper new product development.
AnaSpec, Eurogentec Group is pleased to be the first in the industry to establish a new product line of zebrafish specific (Z-Fish™) antibodies to support the increasing needs of researchers.
You are invited to attend Dr. Goburru's webinar The "Learn & Apply" Paradigm in Drug Development on April 18, 2011 at 1:00 pm EST (GMT -5:00) (www.rosaandco.com/webinar). This talk will summarize the state of the art in applying drug-disease-trial modeling to decision-making processes in drug development.
Gateway Analytical will be exhibiting its materials characterization and industrial problem-solving services at booth number 431 at the Materials Research Society Spring Meeting and Exhibit, April 25-29, Moscone West Convention Center, San Francisco.
PBI releases SimLipid, a comprehensive lipid identification tool, supporting lipid MS/MS data analysis and correction of peak intensities for MS lipid profiles with overlapping isotopes.
Ray Miller, Global Business Development Manager in Biomaterials and Specialties, at DuPont Applied BioSciences, will give a presentation at GTC's 2nd Annual Biobased Chemicals - Inception to Market Conference on July 7-8, 2011 in San Francisco, CA.
Signaling an aggressive escalation of his campaign to promote his status as the creator of the first functioning prototype of warp drive, research and development engineer Marshall Barnes announces the imminent release of a "defining work" on the real physics of warp drive.
Aquatic Informatics has been named to the "Ready to Rocket" list for the last four years based on its consistent growth and high potential to accelerate that growth in 2011.
Onyx Scientific excel in streamlining GMP-approved processes and difficult-to-synthesise APIs. Their compliance standards minimise impurities, reduce costs and significantly improve timelines for phase I and II clinical studies.
Enertia Engineering Ltd., a leading electrical equipment company, is pleased to announce, after 2 years of research, development, and commercialization, the EnerPulsar Anti-Islanding protection system is now commercially available in North America.
With two thirds of all clinical trials being outsourced and inefficiencies leading to 70% of all trials failing to complete on time; establishing CRO accountability, running trials in emerging markets and entering into risk sharing partnerships are discussed as possible solutions.
Particle size advancements in nasal spray suspensions using Raman chemical imaging will be presented by scientists at Gateway Analytical at the Pittcon Conference and Expo 2011.
Susan Schneider, Director, Discovery Medicine, GSK Ophthalmology will give a featured presentation at GTC's 3rd Ocular Disease Drug & Discovery Conference, May 26- 27, 2011 in Boston, MA.
Barbara Wirostko, Chief Medical Officer of Altheos will give a featured presentation at GTCbio's 3rd Ocular Disease & Drug Discovery Conference, May 26-27, 2011 in Boston, MA.
William C. Shakespeare, Ph.D., Vice President, Drug Discovery at ARIAD Pharmaceuticals to give featured presentation on "Tackling Mutation-Based Resistance in Kinase Drug Discovery: Ponatinib, a Pan-BCR-ABL Inhibitor and AP26113, A Next Generation ALK Inhibitor" at GTCbio's 6th Protein Kinases in Drug Discovery Conference on May 26-27, 2011 in Boston, MA.
ISO 17025-accredited radiocarbon dating lab Beta Analytic Inc., co-sponsors the BioSystematics Berlin 2011 congress held in Berlin, Germany, from February 21 to February 27, 2011. This year's congress is composed of three major events - the 7th International Congress of Systematic and Evolutionary Biology (ICSEB VII) of the International Organization for Systematic and Evolutionary Biology (IOSEB).
Nobel prize based research into telomeres and the enzyme telomerase coupled with research into telomerase activation and a rare molecule in a natural supplement extracted from the root of an Asian plant.
AnaSpec, Eurogentec Group, is pleased to offer two recombinant proteins for use in Neurodegenerative Disease Research, α-synuclein (SNCA) and β-synuclein (SNCB). Both α-synuclein and β-synuclein are expressed and purified from E. coli.
Beta Analytic, Inc., invites participants of the 2nd Annual Next Generation Bio-Based Chemicals Summit to visit its booth during the four-day event to be held at the Hilton San Diego Resort & Spa in San Diego, California.
Satisfied Users & 
Approved Press Releases
